Navigation Links
Access Pharmaceuticals Announces $2.7 Million New Equity
Date:1/29/2008

- Private Placement of Convertible Preferred Stock -

DALLAS, Jan. 29 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) announced today that it has executed agreements for $2.7 million in new equity. The Company has entered into agreements with institutional and accredited investors to purchase an aggregate of $2.7 million in gross proceeds of the Company's Series A Convertible Preferred Stock. This equity is in addition to the $9.5 million in gross proceeds announced in November 2007.

"We are excited to complete this placement of the Company's Series A Convertible Preferred Stock," said Jeffrey B. Davis, Access' CEO. "The additional new capital will enable us to fund a number of key objectives including pursuing and expanding our clinical trial program for Access' anti-cancer compound, ProLindac, a novel, proprietary DACH platinum which is currently in Phase 2 development."

Pursuant to the securities purchase agreements, the Company will, subject to the completion of the closing, issue to the new investors Series A Convertible Preferred Stock initially convertible into 908,000 shares of the Company's common stock. The investors will also receive warrants to purchase an additional 454,000 shares of the Company's common stock at an exercise price of $3.50. Upon closing, certain of the Company's Series A Convertible Preferred Stock will be amended.

Closing of the transaction is subject to the fulfillment of customary and usual closing conditions.

About ProLindac(TM):

ProLindac is a novel DACH platinum prodrug which has been shown to be active in a wide variety of solid tumors in both preclinical models and in human trials. Access believes that ProLindac's unique molecular design potentially could eliminate some of the toxic side effects seen in the currently marketed DACH platinum, Eloxatin, which has sales in excess of $2 billion.

About Access:

Access Pharmaceuticals
'/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Clinical and Economical Considerations For IV Push Drug Delivery by Industry Expert Richard Rosenfeld Is Now Accessible on Expert411.com for Media and Professional Use
2. Access Pharmaceuticals Appoints Jeffrey B. Davis as CEO
3. Neptune Technologies & Bioressources Inc. Secures Access to Nationwide Consumer Mass Market in the United States
4. Access Pharmaceuticals Announces $19.5 Million Recapitalization
5. Access Genetics Announces New Executive Appointments
6. Pharmasset Accesses up to $30 Million of Working Capital
7. Monitorforhire.com Adds Mobile Phone Capability Further Speeding Access to Experienced Monitors
8. CorVel Corporation Medical Provider Network Adds New Providers to Increase Savings and Improve Access to Care
9. GeneGo Enters Multi-Year Agreement With Bristol Myers Squibb for Access to GeneGo Software Suite and Databases
10. Access Highlighted in Recent BusinessWeek Article
11. Concuity Announces the Launch of Its New Fully Accessible Website - Concuity.Com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... , May 28, 2015  GenVec, Inc. (Nasdaq: ... CEO, Douglas J. Swirsky , will present a ... at 11 a.m. EDT on Thursday, June 4, 2015. ... Mr. Swirsky,s presentation will be available at the following ... available on GenVec,s website.  To access, visit www.genvec.com ...
(Date:5/28/2015)... Californiaa (PRWEB) May 28, 2015 Glenn ... “ The Changing Landscape of EMR/EHR Clinical Data Integration ... Meeting taking place in Washington, DC on June 14th-18th. ... challenges of integrating EMR/EHR systems with EDC, and will ... opportunities brought by eSource and electronic health records/electronic medical ...
(Date:5/28/2015)... 28, 2015 American Process Inc. ... Ridge, TN) recently signed a joint agreement ... plastic resins using nanocellulose, a rapidly emerging high ... printing is the limited number of feedstock materials ... strength to printed parts for load bearing applications. ...
(Date:5/28/2015)... Clinerion, an eClinical technology ... the Alliance for Clinical Research Excellence and ... operating in the public interest and dedicated ... quality, safety, integrity and operational effectiveness in ... pleased to announce their partnership for accelerating ...
Breaking Biology Technology:GenVec To Present At The Jefferies Healthcare Conference 2Clinovo Presents at the DIA 2015 51st Annual Meeting in Washington, DC on June 14th-18th 2American Process Inc. Announces Partnership with Oak Ridge National Laboratory to Make 3D Printing Plastic Resins Stronger and More Sustainable 2American Process Inc. Announces Partnership with Oak Ridge National Laboratory to Make 3D Printing Plastic Resins Stronger and More Sustainable 3Clinerion and ACRES Partner on Patient Recruitment and Risk-Based Quality Management 2Clinerion and ACRES Partner on Patient Recruitment and Risk-Based Quality Management 3
... most Americans take the safety of their drinking water ... within minutes, says Prof. Abraham Katzir of Tel Aviv ... the threat of contamination due to industrial spillage, natural ... system to monitor the safety of a building or ...
... with inoperable lung cancer is able to receive stereotactic ... told Donald Bickford, 71, that due to the weakened ... option for removing his lung tumor. To treat the ... here, prescribed a type of non-invasive radiosurgery using the ...
... Cellular Bioengineering, Inc. (CBI) announces it is developing a ... medicine and other consumables, but can also be used ... parts, great works of art, currency, electronic components, high ... the Multimedia News Release go to: ...
Cached Biology Technology:Monitoring water through a snake's eyes 2Monitoring water through a snake's eyes 3Doctors in New Hampshire Now Treating Cancer with Non-Invasive Image-Guided Radiosurgery Using Novalis Tx(TM) Technology 2Doctors in New Hampshire Now Treating Cancer with Non-Invasive Image-Guided Radiosurgery Using Novalis Tx(TM) Technology 3Photos: Breakthrough Technology Enables Edible TruTag(TM) to Prevent Counterfeit Medicine 2Photos: Breakthrough Technology Enables Edible TruTag(TM) to Prevent Counterfeit Medicine 3
(Date:5/19/2015)... , May 19, 2015 ... announced the addition of the  "Genetic Testing ... ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,A recent report, ... in-depth analysis of the current and future ... gene-based tests, their working principles and types ...
(Date:5/14/2015)... and Markets ( http://www.researchandmarkets.com/research/5whpxg/fingerprint ) has announced ... Smart Mobile Devices " report to their offering. ... watershed year for fingerprint sensors in smartphones and tablets, ... fingerprint sensors a raison d,etre in the mobile milieu ... must-have feature in flagship smartphones. The key ...
(Date:5/11/2015)... 2015  Synaptics Incorporated (NASDAQ: SYNA ), ... announced the appointment of Wajid Ali ... reporting to Rick Bergman , President and ... Officer, Kathleen Bayless , who announced her ... Ali brings extensive financial management expertise to Synaptics, ...
Breaking Biology News(10 mins):Global Genetic Testing Market Outlook 2018 2Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2
... New Rochelle, NY, November 20, 2012Mary Ann Liebert, Inc., ... a peer-reviewed journal dedicated to the science and engineering of ... as the first to answer the urgent need for research ... and function in complex natural or human-built environments. Soft ...
... for the treatment of multiple sclerosis and other ... fewer side effects. To achieve this, a team ... Fischer (Max Planck Research Unit for Enzymology of ... (German Center for Neurodegenerative Diseases (DZNE)) have combined ...
... This release is available in Spanish . ... latest technologies U.S. Department of Agriculture (USDA) scientists are adding ... bacteria to food. Agricultural Research Service (ARS) scientists ... in Gainesville, Fla., are using an insect growth regulator called ...
Cached Biology News:'Soft Robotics': A groundbreaking new journal on engineered soft devices that Interact with Living Systems 2Combination of two pharmaceuticals proves effective in the treatment of multiple sclerosis 2Stopping flies before they mature 2
MBS 384 well satellite block unit with height adjusting heated lid, 384 well block holds 1 x 0.04 ml 384 well plate...
384 well block MBSr. Robot compatible block ejection mechanism. Stackable. (384 well block - holds 384 well plate)...
...
Buckets for 2 racks of 5 tubes, type Stago/Hitachi...
Biology Products: